Genetic Apps is proud to announce that it has been chosen as mobile development partner for the OvuSense line of infertility products marketed worldwide by Fertility Focus.
Nearly everyone carries a smartphone around with them these days and the rapid evolution in wearable devices coupled with the need for critical data delivered to the patient is at the heart of this partnership.
Robert Milnes, CEO of Fertility Focus, comments: “We chose Genetic Apps because they already have a deep understanding of the needs of the medical device market, patients and clinicians. There is an increasing feeling in the medical profession that too many mobile products have been launched with insufficient clinical data and testing. Creating a robust mobile architecture is essential to ensure medical devices provide real value and are adopted.”
The OvuSense line will evolve over the coming years to improve women’s health in a number of revolutionary ways.
For more information about OvuSense visit www.ovusense.com.